Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2025-12-25 @ 11:10 PM
Study NCT ID:
NCT01549067
Status:
UNKNOWN
Last Update Posted:
2012-03-14
First Post:
2012-03-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D015179', 'term': 'Colorectal Neoplasms'}], 'ancestors': [{'id': 'D007414', 'term': 'Intestinal Neoplasms'}, {'id': 'D005770', 'term': 'Gastrointestinal Neoplasms'}, {'id': 'D004067', 'term': 'Digestive System Neoplasms'}, {'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D004066', 'term': 'Digestive System Diseases'}, {'id': 'D005767', 'term': 'Gastrointestinal Diseases'}, {'id': 'D003108', 'term': 'Colonic Diseases'}, {'id': 'D007410', 'term': 'Intestinal Diseases'}, {'id': 'D012002', 'term': 'Rectal Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'CROSS_SECTIONAL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 3700}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2011-09'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2012-03', 'completionDateStruct': {'date': '2012-12', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2012-03-13', 'studyFirstSubmitDate': '2012-03-06', 'studyFirstSubmitQcDate': '2012-03-06', 'lastUpdatePostDateStruct': {'date': '2012-03-14', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2012-03-08', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2012-12', 'type': 'ESTIMATED'}}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Advanced', 'Colorectal Cancer', 'Targeted chemotherapy', 'Surgery', 'Radiotherapy'], 'conditions': ['Advanced Malignant Neoplasm', 'Colorectal Cancer']}, 'descriptionModule': {'briefSummary': 'Collect the real clinical background of advanced colorectal cancer c of China.', 'detailedDescription': 'The Primary Objectives of this study is collect the real clinical background of advanced colorectal cancer treatment situation of China. The Secondary Objectives is the mutation of K-ras , targeting therapy , use present situation of cetuximab and liver metastases treatment situation of colorectal cancer patients.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Advanced Colorectal Cancer', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patients with histologically or cytologically confirmed diagnosis of metastatic colorectal cancer.\n\nExclusion Criteria:\n\n* Patients with histologically or cytologically confirmed diagnosis other than metastatic colorectal cancer.'}, 'identificationModule': {'nctId': 'NCT01549067', 'acronym': 'Sprit', 'briefTitle': 'The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey', 'organization': {'class': 'OTHER', 'fullName': 'Chinese Medical Doctor Association'}, 'officialTitle': 'The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey', 'orgStudyIdInfo': {'id': 'Sprit'}}, 'contactsLocationsModule': {'locations': [{'city': 'Beijing', 'state': 'Beijing Municipality', 'status': 'RECRUITING', 'country': 'China', 'contacts': [{'name': 'Lin Shen, MD', 'role': 'CONTACT', 'email': 'lin100@medmail.com.cn', 'phone': '010-88140650'}, {'name': 'Lin Shen, MD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Peking University Cancer Hospital', 'geoPoint': {'lat': 39.9075, 'lon': 116.39723}}, {'city': 'Zhongshan', 'state': 'Guangzhou', 'status': 'RECRUITING', 'country': 'China', 'contacts': [{'name': 'Rui-hua Xu, MD, PhD', 'role': 'CONTACT', 'email': 'xurh@sysucc.org.cn', 'phone': '020-87343468'}, {'name': 'Rui-hua Xu, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Sun Yat-sen University Cancer Center', 'geoPoint': {'lat': 22.52306, 'lon': 113.37912}}], 'centralContacts': [{'name': 'Lin Shen, MD', 'role': 'CONTACT', 'email': 'lin100@medmail.com.cn', 'phone': '010-88140650'}, {'name': 'Rui-hua Xu, MD, PhD', 'role': 'CONTACT', 'email': 'xurh@sysucc.org.cn', 'phone': '020-87343468'}], 'overallOfficials': [{'name': 'Lin Shen, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Peking University Cancer Hospital & Institute'}, {'name': 'Ruihua Xu, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Sun Yat-sen University'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Chinese Medical Doctor Association', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': 'Lin Shen，MD & Ruihua Xu，MD、PhD', 'investigatorAffiliation': 'Chinese Medical Doctor Association'}}}}